Prognostic impact of comorbidities on outcomes of patients (pts) with relapsed or refractory large B-cell lymphoma (r/r LBCL) treated with chimeric antigen receptor T-cell therapy (CART) Meeting Abstract

  

Authors:	Greenbaum, U.; Hashmi, H.; Elsawy, M.; Kim, S.; Moskop, A.; Awan, F. T.; Farooq, U.; Ganguly, S.; Hematti, P.; Jain, M. D.; Kebriaei, P.; Locke, F. L.; Mead, E.; Nishihori, T.; Olson, A. L.; Pennisi, M.; Perales, M. A.; Geethakumari, P. R.; Shouval, R.; Shpall, E. J.; Magalhaes-Silverman, M. M.; Strouse, C.; Turtle, C. J.; Vallurupalli, A.; Wudhikam, K.; Pasquini, M. C.; Ahmed, S.; Sorror, M.
Abstract Title:	Prognostic impact of comorbidities on outcomes of patients (pts) with relapsed or refractory large B-cell lymphoma (r/r LBCL) treated with chimeric antigen receptor T-cell therapy (CART)
Meeting Title:	64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	140
Issue:	Suppl. 1
Meeting Dates:	2022 Dec 10-13
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2022-11-15
Start Page:	4636
End Page:	4638
Language:	English
ACCESSION:	WOS:000893223204290
DOI:	10.1182/blood-2022-169452
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/205059